KOSUNI KOREA
Korean News in English
Business

Nierslab's IPO Preparation Steps and Essential Procedures Explained

Published September 23, 2026 · 3 views
Nierslab's IPO Preparation Steps and Essential Procedures Explained

Nierslab's IPO Preparation Steps

Nierslab has received pre-review approval for a KOSDAQ listing, having passed technical evaluation with a 'Double A' rating. The company aims to enter the KOSDAQ market in 2026. Nierslab holds 126 patents in defense drone technology and has successfully integrated its high-speed interception drone 'Kaiden' into the U.S. Army anti-drone system.

Nierslab passed technical evaluation with a 'Double A' rating on December 15, 2025, and received pre-review approval for KOSDAQ listing on June 25, 2026. This official recognition of technological excellence in the defense drone sector has laid a solid foundation for its upcoming listing process.

Reaching 17.4 billion won in first-half 2026 sales and recording its first quarterly profit through Middle East exports was an important milestone in Nierslab's IPO preparation. This achievement demonstrated successful global market entry based on technological capabilities.

니어스랩 상장 준비 단계와 필수 절차 완전 정리 설명 이미지

Essential Steps for Nierslab's Listing Process

Pre-review approval is the first major hurdle in the listing process. Nierslab cleared this step on June 25, 2026, and subsequently submitted its securities registration statement to begin formal listing procedures.

The securities registration statement is a mandatory document detailing the company's financial status, business plans, and future strategies. Nierslab submitted this document on June 26, 2026, marking the start of its listing process.

Passing technical evaluation with 'Double A' rating demonstrated Nierslab's technological excellence in defense drones, providing investors with high-confidence information. This is a key factor showcasing Nierslab as a technology-focused company.

Key Achievements and Performance During IPO Preparation

Nierslab holds 126 patents in the defense drone sector. These represent the fruits of technological investment and have served as an important asset during its IPO preparation.

Reaching 17.4 billion won in first-half 2026 sales and recording its first quarterly profit through Middle East exports demonstrated successful execution of its IPO strategy. This achievement, based on verified performance in overseas markets, has established a foundation for continued growth after listing.

The public offering P/E ratio is estimated at 44-47 times, indicating investors' high valuation of Nierslab's growth potential. The strong evaluation appears to reflect the company's technological competitiveness in defense drones and its successful global market entry.

Key Events During IPO Preparation

On December 15, 2025, passing technical evaluation with 'Double A' rating was Nierslab's first major achievement. This official recognition of technological excellence laid a solid foundation for its future listing process.

June 25, 2026 marked the second key milestone when Nierslab received pre-review approval for KOSDAQ listing, confirming passage through a critical stage in the listing procedure. Following this, Nierslab submitted its securities registration statement to begin formal listing procedures.

On July 15, 2026, achieving 17.4 billion won in first-half sales and recording its first quarterly profit through Middle East exports demonstrated significant performance improvement during IPO preparation. This served as proof of successful technology deployment and global market strategy execution.

On August 6, 2026, the KOSDAQ listing date (August 24) was confirmed, with Nierslab targeting a minimum offering price of 30,000 won. This is one of the most important goals in Nierslab's IPO strategy, based on capital improvement plans and funding requirements for mass production.

Analysis of Key Factors Behind IPO Preparation

The primary reason for Nierslab's pre-review approval was its technological excellence and performance improvements in the defense drone sector. The 126 patents and 'Double A' technical evaluation result served as important assets during the listing process.

Successfully integrating high-speed interception drone 'Kaiden' into the U.S. Army anti-drone system demonstrated verified technological capability in global markets, contributing to investor confidence during IPO preparation.

The achievement of 17.4 billion won in first-half sales and its first quarterly profit through Middle East exports reflected performance improvements. This milestone provided positive signals to investors as a key success in the IPO strategy.

The public offering P/E ratio of 44-47 times indicates that Nierslab's growth potential has been highly valued by investors. This appears to reflect the company's technological competitiveness in defense drones and its successful global market entry performance.

Key Information to Verify During IPO Preparation

Nierslab has received pre-review approval for KOSDAQ listing, having passed technical evaluation with 'Double A' rating, aiming for a 2026 KOSDAQ debut. This officially recognizes technological excellence in the defense drone sector.

With 126 patents and successful integration of high-speed interception drone 'Kaiden' into the U.S. Army anti-drone system, Nierslab has established important assets for its IPO preparation. These factors contribute to providing investors with high-confidence information.

The achievement of 17.4 billion won in first-half sales and its first quarterly profit through Middle East exports represents performance improvements during IPO preparation. This milestone provided positive signals to investors as a key success in the strategy.

The public offering P/E ratio of 44-47 times indicates high investor valuation of Nierslab's growth potential, reflecting technological competitiveness in defense drones and successful global market entry.

Frequently Asked Questions

When was Nierslab's pre-review approval for listing?

Nierslab received KOSDAQ listing pre-review approval on June 25, 2026.

When did Nierslab pass its technical evaluation 'Double A' rating?

Nierslab passed the technical evaluation with a 'Double A' rating on December 15, 2025.

What is Nierslab's public offering P/E ratio?

Nierslab's public offering P/E ratio is estimated at 44-47 times, indicating high valuation by investors.

Frequently Asked Questions

Nierslab has secured pre-review approval for KOSDAQ listing and passed technical evaluation with 'Double A' rating, aiming to enter the KOSDAQ market in 2026. The company holds 126 patents in defense drones and has successfully integrated its high-speed interception drone 'Kaiden' into the U.S. Army anti-drone system.

Reaching 17.4 billion won in first-half sales and recording its first quarterly profit through Middle East exports was an important achievement during IPO preparation. The public offering P/E ratio is 44-47 times, with a target to secure the minimum offering price of 30,000 won.

Nierslab's technological excellence and performance improvements played crucial roles in its IPO preparation process. These factors have proven the company's competitiveness in defense drones and success in global market entry strategy.

Read More Related Articles

You can view similar articles on this topic all at once.

View Related Articles

FAQ

When was Nierslab's pre-review approval for listing?

Nierslab received KOSDAQ listing pre-review approval on June 25, 2026.

When did Nierslab pass its technical evaluation 'Double A' rating?

Nierslab passed the technical evaluation with a 'Double A' rating on December 15, 2025.

What is Nierslab's public offering P/E ratio?

Nierslab's public offering P/E ratio is estimated at 44-47 times, indicating high valuation by investors.

Korean Source

This article is an English localization of a Korean-language report from BlogScore. Original: 니어스랩 상장 준비 단계와 필수 절차 완전 정리